Hyponatremia unleashes neutrophil extracellular traps elevating life-threatening pulmonary embolism risk.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
05 Nov 2024
Historique:
medline: 31 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: ppublish

Résumé

Neutrophil extracellular traps (NETs), essential for controlling infections, can induce various pathologies when dysregulated. Known triggers for infection-independent NETs release exist, yet a comprehensive understanding of the conditions prompting such responses is lacking. In this study, we identify hyponatremia as an independent inducer of NETs release, a common clinical condition that disrupts sodium/calcium exchange within neutrophils. This disruption leads to an excess of intracellular calcium, subsequent elevation of reactive oxygen species (ROS), and the citrullination of histone H3, culminating in the activation of NETs-release pathways. Notably, under hyponatremic conditions, this mechanism is exacerbated during infectious states, leading to the deposition of NETs in the lungs and increasing the risk of life-threatening pulmonary embolism. Our findings underscore the critical role of sodium and calcium homeostasis in neutrophil functionality and provide insights into the pathogenesis of hyponatremia-associated diseases, highlighting potential therapeutic interventions targeting NETs dynamics.

Identifiants

pubmed: 39475645
doi: 10.1073/pnas.2404947121
doi:

Substances chimiques

Reactive Oxygen Species 0
Calcium SY7Q814VUP
Histones 0
Sodium 9NEZ333N27

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2404947121

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Minoru Inoue (M)

Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.
Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan.
Radiation and Proton Therapy Center, Shizuoka Cancer Center Hospital, Shizuoka 411-8777, Japan.

Kazuo Takayama (K)

Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan.

Rina Hashimoto (R)

Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan.

Masahiro Enomoto (M)

Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.

Naoki Date (N)

Department of Thoracic Surgery, Kyoto University Hospital, Kyoto 606-8507, Japan.

Akihiro Ohsumi (A)

Department of Thoracic Surgery, Kyoto University Hospital, Kyoto 606-8507, Japan.

Takashi Mizowaki (T)

Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH